×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: NAD+ Precursor Therapy for Neurodegenerative Diseases
therapeutic
1,336 words
KG: NAD+
2026-03-22
kind:therapeutic
section:therapeutics
state:published
Contents
NAD+ Precursor Therapy for Neurodegenerative Diseases
💊
Therapeutic Info
Name
NAD+
Summary
Page for NAD+ Precursor Therapy for Neurodegenerative Diseases
Key Genes/Proteins
SIRT1
,
AMPK
,
CX43
,
PARP1
Related Pathways
Cellular Processes
Linked Hypotheses
6 hypotheses
Knowledge Graph
Related Hypotheses (30)
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68
PARP1 Inhibition Therapy
Score: 0.58
Vagal Afferent Microbial Signal Modulation
Score: 0.52
Vocal Cord Neuroplasticity Stimulation
Score: 0.50
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67
SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc
Score: 0.60
Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromat
Score: 0.52
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68
Transcriptional Autophagy-Lysosome Coupling
Score: 0.66
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
CYP46A1 Overexpression Gene Therapy
Score: 0.63
Digital Twin-Guided Metabolic Reprogramming
Score: 0.61
Senescence-Activated NAD+ Depletion Rescue
Score: 0.60
Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59
Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.56
Circadian Clock-Autophagy Synchronization
Score: 0.55
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55
Senescent Cell Mitochondrial DNA Release
Score: 0.54
Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51
Senescence-Associated Myelin Lipid Remodeling
Score: 0.51
SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK
Score: 0.51
Ganglioside Rebalancing Therapy
Score: 0.50
Autophagosome Maturation Checkpoint Control
Score: 0.49
Lysosomal Calcium Channel Modulation Therapy
Score: 0.49
Orexin-Microglia Modulation Therapy
Score: 0.49
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.48
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48
Show 25 more
Related Analyses (30)
Metabolomic signatures of neurodegeneration and energy metab
neurodegeneration · failed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Show 25 more
Related Experiments (23)
NAD depletion effects on monocyte/macrophage differentiation
exploratory · proposed · Score: 0.90
Germfree mouse colonocyte energy metabolism analysis
validation · proposed · Score: 0.90
FK866 treatment in DSS-induced colitis mouse model
validation · proposed · Score: 0.90
FK866 in azoxymethane/DSS colitis-associated cancer model
validation · proposed · Score: 0.85
Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40
s:** - Temporal analysis showing mitochondrial defects prece
falsification · proposed · Score: 0.40
Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?
clinical · proposed · Score: 0.40
DNA Damage Repair Deficiency Validation Study in Parkinson's
clinical · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Microglial Aging and Immune Memory in Neurodegeneration — Tr
validation · proposed · Score: 0.40
Normal Aging to Alzheimer's Disease Transition Trigger — Ide
validation · proposed · Score: 0.40
Peroxisomal Dysfunction Validation in Parkinson's Disease
validation · proposed · Score: 0.40
Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer's
clinical · proposed · Score: 0.40
Sirtuin Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40
Sirtuin Pathway Dysfunction Validation in Parkinson's Diseas
clinical · proposed · Score: 0.40
iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90
Gandouling protection against brain injury in Wilson's disea
validation · proposed · Score: 0.90
AMPK knockdown validation experiment
exploratory · proposed · Score: 0.88
iPSC-NPC transplantation in ICH animal model
validation · proposed · Score: 0.85
Epigenetic Clocks in Neurodegeneration — Causal Drivers or P
validation · proposed · Score: 0.40
H₂O₂-induced oxidative stress in isolated chondrocytes
exploratory · proposed · Score: 0.90
Unilateral anterior crossbite (UAC) model of TMJOA in rats
validation · proposed · Score: 0.90
Cx43-β-catenin protein-protein interaction analysis
exploratory · proposed · Score: 0.80
Show 18 more
See Also (5)
Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: inhibits
APP Gene Dosage Reduction Therapy for Down Syndrome
idea · KG edge: inhibits
CD38 Molecule (CD38)
gene · KG edge: degrades
AMPK (AMP-Activated Protein Kinase)
entity · KG edge: activates
ATP P2X3 Receptor Neurons
cell · KG edge: causes
Knowledge Graph (10 edges)
NAD+
activates
SIRT1
NAD+
regulates
SIRT1
NAD+
protects_against
BLOOD-BRAIN BARRIER DAMAGE
NAD+
associated_with
Cellular Processes
NAD+
modulates
inflammation
AMPK
contributes_to
NAD+
PARP
degrades
NAD+
SIRT
degrades
NAD+
CX43
regulates
NAD+
PARP1
regulates
NAD+